Sun Pharma to discontinue non-strategic business units
Advertisement
As a part of its integration process with Ranbaxy Laboratories, Sun Pharma is likely to discontinue certain non-strategic businesses to have a smooth and sustainable transition. Sun Pharma had acquired Ranbaxy in a $4 billion deal last year.
As implied by the Sun Pharma Managing Director Dilip Shanghvi said the decision to discontinue the non-strategic part of the business is also coupled with the fact of the company’s foreseeing a loss due to integration charges. However, Sun Pharma eyes synergy benefits of $300 million (around Rs 2,000 crore) by 2017-18 from the merger.
As implied by the Sun Pharma Managing Director Dilip Shanghvi said the decision to discontinue the non-strategic part of the business is also coupled with the fact of the company’s foreseeing a loss due to integration charges. However, Sun Pharma eyes synergy benefits of $300 million (around Rs 2,000 crore) by 2017-18 from the merger.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.